Sanofi Consumer Healthcare makes debut on BSE, NSE
New Delhi: Sanofi Consumer Healthcare India on Friday said it has been listed on the BSE and the National Stock Exchange.
Sanofi Consumer Healthcare India has emerged as a distinct legal entity following its demerger from Sanofi India.
The demerger, executed under the Scheme of Arrangement, was sanctioned by the Mumbai bench of the National Company Law Tribunal and became effective on June 1, 2024.
"India's consumer healthcare market, has vast potential. SCHIL getting listed on the BSE and NSE, marks a critical milestone for us; one that is further expected to strengthen our position and drive sustainable growth within the Indian market," Sanofi Consumer Healthcare India MD Himanshu Bakshi said in a statement.
By evaluating business needs, capitalising on emerging consumer trends in the healthcare space and encouraging a culture of digital innovations, the company seeks to address unmet consumer needs, he added.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.